Laugier-Hunziker Syndrome (LHS)

Laugier-Hunziker Syndrome (LHS)

Julie Scott, DNP
Julie Scott, DNP
Laugier-Hunziker Syndrome |cancerGO

What is Laugier-Hunziker Syndrome (LHS)

Laugier-Hunziker Syndrome (LHS) is a rare disorder that affects the pigment of the skin and mucous membranes of the mouth. LHS is also known as idiopathic lenticular mucocutaneous pigmentation.

LHS is a benign (non-cancerous) condition and does not cause any serious health problems. The main symptom of LHS is the appearance of dark pigmentation on the lips, inside of the mouth, and sometimes on the fingers and toes. The pigmentation is typically brown or black and appears as small, flat spots or patches.

Causes:

The exact cause of LHS is unknown, but it is thought to be a combination of genetic and environmental factors. Some cases of LHS have been associated with mutations in the TERT gene, which is involved in the process of cell division and aging. Other cases have been linked to exposure to certain medications, such as nonsteroidal anti-inflammatory drugs (NSAIDs) and hormonal therapies.

Diagnosis:

LHS is usually diagnosed based on the pigmentation pattern which is characteristic of the disorder, as well as a thorough medical history. In some cases, a skin biopsy may be performed to rule out other conditions that may cause similar symptoms.

Treatment:

Treatment for LHS is usually not necessary as the condition does not cause any health problems. However, if the pigmentation is causing cosmetic concerns, treatment options such as laser therapy, cryotherapy, and topical creams may be considered.

It is important to note that LHS does not increase the risk of developing skin cancer or other health problems. However, it is still important to practice good sun protection habits, such as wearing protective clothing and sunscreen, to prevent damage to the skin

 

Julie Scott, DNP
Julie Scott, DNP
Julie is an oncology certified Oncology Nurse Practitioner with over a decade of medical oncology experience. In addition to her clinical work, she is an accomplished healthcare writer providing oncology content for various publications. She also serves as an adjunct faculty member for a Master's nursing program and a chair for Doctoral nursing students.

Download our
mobile app

Share this post
You may also like
Articles
Cancer Survivorship – Life After treatment
November 7, 2022

Cancer survivorship means different things to different people. For some, it may be a time of reflection and growth. Others may feel on a roller coaster of emotions, from joy to sadness. No matter your experience, there are ways to cope with the challenges of cancer survivorship.  After completing treatment  …

Pinaki Saha

administrator

Articles
Patient Experience: Transparency At End Of Life
April 14, 2023

Transparency is crucial when cancer has metastasized, and the patient is nearing the end of their life. In these circumstances, honest communication between healthcare providers, patients, and their loved ones is essential. It enables patients to make educated and informed decisions about their care and prepares them for the next…

Jenni Daniel BSN, RN

author

Articles
What are clinical trials and why are they important?
December 22, 2022

Clinical trials are research studies to help find new cancer treatments. Every medication or treatment must go through clinical trials to be approved. Clinical trials are an important part of cancer care. There are different phases to clinical trials. Phase I trials are also called dose-finding trials. During this phase,…

Julie Scott, DNP

author

cancerGO gives you access to a community

Where are people to listen, answer questions, share information, and offer valuable and timely advice